Date-Rape Prevention Drug Act Heads to House Floor 8/6/99

Drug War Chronicle, recent top items


recent blog posts "In the Trenches" activist feed


Peder Nelson, [email protected]

On Thursday (8/5), the US House of Representatives Commerce Committee approved by voice vote HR 2130, dubbed the "Hillory J. Farias Date-Rape Prevention Drug Act of 1999" after a young woman from Texas died after reportedly drinking a soda that was laced with a high concentration of GHB. The bill would place GHB (Gamma hydroxybutyric acid) into the Schedule 1 category for all "street" use, and list Ketamine as a Schedule 3 narcotic. The bill was amended to allow completion of a decade long research project that is looking into the effects of treating a rare form of narcolepsy (a daytime sleeping disorder) with GHB. After the project is completed, and if the FDA approves the drug as a medicine, GHB would be rescheduled as a schedule 3 controlled substance.

First synthesized in 1961 by French researcher Henri Laorit, GHB has been used as a general anesthetic, a treatment for insomnia and narcolepsy an aid to childbirth, a treatment for alcoholism and drug abuse, and an anti-anxiety, anti-stress, and anti-depressant agent. During the 1980's it was marketed in the United States as a dietary supplement, until the Food & Drug Administration banned over-the-counter sales of the substance in 1990. Since that time, the popularity of GHB has increased dramatically, particularly as a recreational drug used at raves, dance parties, and clubs, where it is used alone or, more dangerously, in conjunction with drugs like alcohol which can magnify its effects.

GHB's increasing prevalence as a street has coincided with the rise of raves and dance parties in the US. But a spokesman for Congressman Bart Stupak (D-MI), one of the authors of the bill, gave DRCNet another reason for the drug's widespread use. "The popularity of GHB is very much attributable to the advent of the Internet," he said. "We can't regulate people from being dumb, but we can take [GHB] out of the mainstream."

When asked how the Internet made GHB more popular, a spokesman for Congressman Fred Upton (R-MI), the bill's sponsor, said only that "the Internet has made it easier to find a home-brew recipe or purchase and acquire this very insidious drug."

Since 1997, twenty-eight states have passed legislation that increased penalties for illicit use of GHB, prompted by an increase in GHB-related emergency room visits. GHB is reported to lower inhibitions, acting as a depressant similar to alcohol but generally with less toxicity to vital organs. But since over-the-counter sales of GHB were banned, it has been distributed without proper product warnings, labeling or dosage levels, which has likely contributed to its misuse.

Dr. Martin Sharf is a researcher at the Tri-State Sleep Disorder Center of Cincinnati, Ohio, who has studied the effects of GHB for the last seventeen years and hopes to see it approved for medical uses. When DRCNet asked him for a reaction regarding this legislation he commented that, "This is a law enforcement necessity not a medical necessity. There are no good drugs or bad drugs, just better ways of using them."

Critics of the legislation point out that 70% of "acquaintance rape" or "date rape" involves use of alcohol, according to the Department of Justice. As Steven Wm. Fowkes, Executive Director of the Cognitive Enhancement Research Institute, told a California State Legislature committee in 1997, "It is unreasonable to assume that scheduling will eliminate GHB use by criminally inclined individuals any more than alcohol prohibition during the 1920s eliminated alcohol use."

It is unclear what the effect of this legislation could be on the fifteen Investigational New Drug (IND) applications for GHB currently under review by the FDA.

The Vaults of Erowid web site houses a collection of writings about GHB from the academic, popular, and underground press, available online at Visit for the text of HR 2130 or any other federal legislation.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #102, 8/6/99 Portland Judge Rules "Trap and Trace" of Gardening Supply Store Phone Illegal | Date-Rape Prevention Drug Act Heads to House Floor | AUSTRALIA: New South Wales to Heed Experts, Open Safe Injecting Room | Newsbriefs | Decrim Initiatives Filed in Massachusetts for 2000 Ballot | Kubby Case Begins in California, Interpretation of Prop. 215 at Issue | Wife of US Military Commander in Colombia Charged With Drug Trafficking | Methamphetamine Bill Moves Out of Committee
Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]